IMCD completes the acquisition of Swiss based DCS Pharma AG
ROTTERDAM, The Netherlands (December 10, 2019) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and food ingredients, today announces that it
successfully completed the acquisition of Swiss pharmaceutical distributor DCS Pharma AG.
With this acquisition IMCD acquired 90% of the shares in DCS Pharma AG. The remaining 10% will follow per 31 December 2021.
IMCD Aktie jetzt für 4€ handeln - auf Smartbroker.de